Viracta Therapeutics Inc (VIRX)
0.2323
0.00 (0.00%)
USD |
NASDAQ |
Oct 04, 16:00
0.2323
0.00 (0.00%)
After-Hours: 17:29
Viracta Therapeutics Cash from Operations (Quarterly): -9.827M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -9.827M |
| March 31, 2024 | -7.849M |
| December 31, 2023 | -10.03M |
| September 30, 2023 | -10.54M |
| June 30, 2023 | -7.99M |
| March 31, 2023 | -11.34M |
| December 31, 2022 | -7.903M |
| September 30, 2022 | -7.157M |
| June 30, 2022 | -9.034M |
| Date | Value |
|---|---|
| March 31, 2022 | -11.36M |
| December 31, 2021 | -7.211M |
| September 30, 2021 | -7.598M |
| June 30, 2021 | -6.593M |
| March 31, 2021 | 2.551M |
| December 31, 2020 | -4.541M |
| September 30, 2020 | -4.255M |
| June 30, 2020 | -3.60M |
| March 31, 2020 | -3.658M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-11.36M
Minimum
Mar 2022
2.551M
Maximum
Mar 2021
-7.107M
Average
-7.724M
Median
Cash from Operations (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.578M |
| Palatin Technologies Inc | -6.472M |
| iBio Inc | -4.854M |
| Theriva Biologics Inc | -3.452M |
| Oragenics Inc | -1.544M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 11.70M |
| Cash from Financing (Quarterly) | 0.043M |
| Free Cash Flow | -38.24M |
| Free Cash Flow Per Share (Quarterly) | -0.2494 |
| Free Cash Flow Yield | -421.5% |